SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $150,000 | -43.4% | 118,204 | -2.6% | 0.00% | -33.3% |
Q3 2021 | $265,000 | -41.2% | 121,395 | +0.9% | 0.00% | -40.0% |
Q2 2021 | $451,000 | +27.0% | 120,370 | +10.4% | 0.01% | +25.0% |
Q1 2021 | $355,000 | -11.2% | 109,017 | -7.0% | 0.00% | -20.0% |
Q4 2020 | $400,000 | -27.9% | 117,168 | -13.9% | 0.01% | -28.6% |
Q3 2020 | $555,000 | +80.8% | 136,150 | +50.1% | 0.01% | +40.0% |
Q2 2020 | $307,000 | +37.1% | 90,701 | -5.7% | 0.01% | +25.0% |
Q1 2020 | $224,000 | -20.3% | 96,216 | +24.5% | 0.00% | 0.0% |
Q4 2019 | $281,000 | -55.9% | 77,274 | +0.6% | 0.00% | -60.0% |
Q3 2019 | $637,000 | +2.4% | 76,814 | +6.4% | 0.01% | 0.0% |
Q2 2019 | $622,000 | -18.8% | 72,187 | +0.8% | 0.01% | -16.7% |
Q1 2019 | $766,000 | +31.6% | 71,631 | +7.8% | 0.01% | +20.0% |
Q4 2018 | $582,000 | -44.3% | 66,464 | +6.9% | 0.01% | -28.6% |
Q3 2018 | $1,045,000 | -17.5% | 62,198 | +2.9% | 0.01% | -17.6% |
Q2 2018 | $1,267,000 | +31.3% | 60,443 | +0.8% | 0.02% | +30.8% |
Q1 2018 | $965,000 | -16.8% | 59,976 | -2.1% | 0.01% | -13.3% |
Q4 2017 | $1,160,000 | +48.5% | 61,240 | +10.3% | 0.02% | +50.0% |
Q3 2017 | $781,000 | +102.9% | 55,521 | +7.5% | 0.01% | +100.0% |
Q2 2017 | $385,000 | +15.3% | 51,664 | +0.7% | 0.01% | +25.0% |
Q1 2017 | $334,000 | +47.8% | 51,326 | +0.5% | 0.00% | +33.3% |
Q4 2016 | $226,000 | -10.0% | 51,059 | -5.1% | 0.00% | 0.0% |
Q3 2016 | $251,000 | -18.0% | 53,776 | +15.5% | 0.00% | -25.0% |
Q2 2016 | $306,000 | +1.7% | 46,577 | -1.7% | 0.00% | 0.0% |
Q1 2016 | $301,000 | +1.7% | 47,402 | -3.5% | 0.00% | 0.0% |
Q4 2015 | $296,000 | +1.0% | 49,135 | +0.3% | 0.00% | 0.0% |
Q3 2015 | $293,000 | -14.6% | 48,967 | -2.4% | 0.00% | 0.0% |
Q2 2015 | $343,000 | +8.5% | 50,155 | -3.8% | 0.00% | +33.3% |
Q1 2015 | $316,000 | -12.5% | 52,121 | +0.1% | 0.00% | -25.0% |
Q4 2014 | $361,000 | -15.5% | 52,075 | -0.7% | 0.00% | -20.0% |
Q3 2014 | $427,000 | -5.7% | 52,455 | -5.8% | 0.01% | 0.0% |
Q2 2014 | $453,000 | +4.4% | 55,694 | +0.6% | 0.01% | +25.0% |
Q1 2014 | $434,000 | -13.2% | 55,355 | -2.0% | 0.00% | -20.0% |
Q4 2013 | $500,000 | +5.9% | 56,458 | +0.3% | 0.01% | 0.0% |
Q3 2013 | $472,000 | +8.0% | 56,311 | -3.8% | 0.01% | 0.0% |
Q2 2013 | $437,000 | -0.5% | 58,559 | -0.5% | 0.01% | 0.0% |
Q1 2013 | $439,000 | – | 58,868 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |